The development of new antimicrobials and other biomedical interventions alone will not be enough to fight AMR, controlling Hospital Acquired Infections (HAIs) will be key. Uma Bala Pamidimukkala plays the role of a Superbugs Inspector in a city hospital. She is an Additional Professor in the Department of Microbiology at Nizam’s Institute of Medical Sciences (NIMS), Hyderabad, where her work involves the identification of disease-causing microorganisms and providing information to doctors on whether or not these pathogens are susceptible to antimicrobials. This in turn helps doctors to optimise treatment and in avoiding inappropriate use of antimicrobials. Uma Bala is also a part of the Antimicrobial Stewardship Programme that organizes different workshops to spread awareness on the different aspects of infection, disease control and its prevention to ensure infections, including AMR infections, do not escape into the environment. In this interview, Uma Bala shares her experience of working in public hospitals that are proven to be hubs for HAIs and AMR infections and talks about the various challenges that one faces stopping the spread of AMR in these settings.
Suman Kapur and her team based at BITS Pilani, Hyderabad, have developed a unique device called RightBiotic that rapidly identifies antibiotic sensitivity of pathogens found in human Urinary Tract Infections (UTI) and helps a medical professional identify the right kind of antibiotics to use to treat the infection. For her efforts, Suman has received the All-India Women Entrepreneur Award 2021 in the category of Super Achiever by the Delhi Management Association. She was also recognized as one of 100 Women Achievers by the President of India in 2015. The RightBiotic team was awarded the Gandhian Young Technological Innovation Award in 2015. In this interview, Suman takes us through the science behind RightBiotic and why it is an effective biomedical tool to control the rise of superbugs.
Jyoti Joshi, Head of South Asia, Center for Disease Dynamics Economics and Policy (CDDEP), is a public health researcher studying drivers of antimicrobial resistance (AMR) and has co-authored a critical scoping report on the Antimicrobial Resistance Research Landscape in India. Jyoti has also been closely involved in improving immunization coverage across India including the Mission Indradhanush of the Government of India. In this interview, Jyoti shares important insights on various aspects of AMR to help us understand that solving this crisis would require action at every level of society across the world.
Somdatta Karak and Disha Chauhan | Many antibiotics work by inhibiting cell wall formation in bacteria. But in a bid to survive as most other living organisms, bacteria mutate and evolve into antibiotic-resistant superbugs. In this zine by Somdatta Karak (words) and Disha Chauhan (art), learn about how Dr Manjula Reddy and her team's research … Continue reading Mapping bacterial growth to fight superbugs